ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 176 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,381,463 | -50.8% | 12,133 | -66.2% | 0.01% | -63.6% |
| Q2 2020 | $2,809,000 | +202.7% | 35,910 | +71.9% | 0.03% | +230.0% |
| Q1 2020 | $928,000 | -33.3% | 20,889 | -35.9% | 0.01% | -9.1% |
| Q4 2019 | $1,391,000 | -9.3% | 32,568 | +50.8% | 0.01% | +57.1% |
| Q3 2016 | $1,533,000 | +1.7% | 21,600 | -29.9% | 0.01% | 0.0% |
| Q2 2016 | $1,507,000 | -11.2% | 30,800 | +14.9% | 0.01% | -30.0% |
| Q1 2016 | $1,697,000 | -80.5% | 26,800 | -70.4% | 0.01% | -80.0% |
| Q3 2015 | $8,710,000 | – | 90,430 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |